ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,912 | +5.1% | 4,940 | +0.8% | 0.00% | – |
Q2 2023 | $61,740 | +89378.3% | 4,900 | -7.5% | 0.00% | -100.0% |
Q1 2023 | $69 | -97.4% | 5,297 | -96.4% | 0.00% | -95.2% |
Q4 2022 | $2,624 | -97.3% | 148,757 | +2101.5% | 0.02% | +2000.0% |
Q3 2022 | $99,000 | 0.0% | 6,757 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $99,000 | -61.3% | 6,680 | -41.3% | 0.00% | -50.0% |
Q1 2022 | $256,000 | +60.0% | 11,380 | +43.9% | 0.00% | +100.0% |
Q4 2021 | $160,000 | +52.4% | 7,910 | +1.0% | 0.00% | 0.0% |
Q3 2021 | $105,000 | -27.6% | 7,830 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $145,000 | +22.9% | 7,830 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $118,000 | +4.4% | 7,830 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $113,000 | +88.3% | 7,830 | +5.4% | 0.00% | – |
Q3 2020 | $60,000 | +252.9% | 7,430 | +199.6% | 0.00% | – |
Q2 2020 | $17,000 | +70.0% | 2,480 | +66.4% | 0.00% | – |
Q1 2020 | $10,000 | -94.1% | 1,490 | -91.3% | 0.00% | -100.0% |
Q4 2019 | $169,000 | -10.6% | 17,200 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $189,000 | -3.1% | 17,200 | +2.4% | 0.00% | 0.0% |
Q2 2019 | $195,000 | +21.9% | 16,800 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $160,000 | +5.3% | 16,800 | +6.3% | 0.00% | 0.0% |
Q4 2018 | $152,000 | -32.4% | 15,800 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $225,000 | +18.4% | 15,800 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $190,000 | -2.6% | 15,800 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $195,000 | -10.6% | 15,800 | +5.3% | 0.00% | 0.0% |
Q4 2017 | $218,000 | +2.3% | 15,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $213,000 | +11.5% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $191,000 | +0.5% | 15,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $190,000 | +24.2% | 15,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $153,000 | -22.7% | 15,000 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $198,000 | +3.7% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $191,000 | -3.5% | 15,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $198,000 | -14.3% | 15,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $231,000 | +24.2% | 15,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $186,000 | -9.3% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $205,000 | +14.5% | 15,000 | 0.0% | 0.00% | +50.0% |
Q1 2015 | $179,000 | -6.8% | 15,000 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $192,000 | -4.5% | 15,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $201,000 | -16.6% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $241,000 | -10.7% | 15,000 | 0.0% | 0.00% | -25.0% |
Q1 2014 | $270,000 | +16.4% | 15,000 | 0.0% | 0.00% | +33.3% |
Q4 2013 | $232,000 | +4.0% | 15,000 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $223,000 | +14.9% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $194,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |